Skip to content

Impact of Self-tonometry on Glaucoma Treatment Decision.

Impact of Self-tonometry With iCare Home ® on Glaucoma Treatment Decision.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04888156
Enrollment
133
Registered
2021-05-17
Start date
2021-05-10
Completion date
2022-02-01
Last updated
2022-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Glaucoma Capsulare, Glaucoma, Open-Angle, OHT - Ocular Hypertension

Keywords

glaucoma, self-tonometry, treatment, IOP peaks

Brief summary

Self-tonometry with iCare Home is performed by one hundred patients annually at Sankt Erik's Eye Hospital. The investigators want to evaluate the impact that self-tonometry results have on the clinician's choice of glaucoma treatment. The investigators also want to evaluate how often pressure peaks occur outside the clinic's opening hours.

Detailed description

Since a few years back, self-tonometry has been available in glaucoma care. Self-tonometry allows patients to measure their eye pressure themselves using a portable tonometer. Sankt Erik's Eye Hospital was the first healthcare provider in Sweden to use this new technology. The investigators have previously conducted studies that have shown good agreement between the measurements made by patients and the gold standard method, e.g. Goldman applanation tonometry (GAT) (Chen, Querat et al. 2016, Querat and Chen 2017). About one hundred patients perform pressure curves with self-tonometry annually. As the method is used regularly, the investigators want to evaluate the impact of self-tonometry results on the clinician's choice of glaucoma treatment. The investigators also want to evaluate how often pressure peaks occur outside the clinic's opening hours and how much they differ from GAT.

Interventions

OTHERUnchanged treatment

Treatment is the same pre- and post self-tonometry

OTHERChanged treatment

Treatment is changed post self-tonometry

Sponsors

St. Erik Eye Hospital
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 18 years * Diagnosed with POAG (primary open-angle glaucoma), PEX (pseudo-exfoliation glaucoma) or OHT (ocular hypertension) * Difference between patients' and staff's iCare Home® measurements less than 5 mmHg at Baseline * Difference between Goldman Applanation tonometry (GAT) and patient's highest iCare Home® measurements less than 7 mmHg at baseline * Monitoring over at least two days

Exclusion criteria

* More than one measurement with iCare Home® tonometer below 5 mmHg * Missing more than one daily measurement with iCare Home® tonometer

Design outcomes

Primary

MeasureTime frameDescription
Clinician's choice of glaucoma treatmentOne monthType of treatment received by patient after performance of self-tonometry with iCare Home

Secondary

MeasureTime frameDescription
Occurence of IOP peaksThree days of self-tonometryOccurence of IOP peaks measured by self-tonometry

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026